VineBrook Homes Tender Offer Results: 2,753,350 Shares Tendered for 909,090 Spots at $33.00 (About 33% Prorated)

The two documents, three weeks apart

On August 14, 2026, VineBrook Homes Trust filed its quarterly report. Inside it, in the note where management assesses whether the company can continue as a going concern, is this sentence:

"As of the date of issuance, the Company does not have sufficient liquidity to satisfy these obligations."

"These obligations" is approximately $612.2 million of debt maturing within twelve months of that date: the NexPoint Homes MetLife Note 1 (March 3, 2027), MetLife Note 2 (August 12, 2027), the JPM Acquisition Facility (July 9, 2027) and the SFR OP Convertible Notes (June 30, 2027).

On September 4, 2026, twenty-one days later, the same company filed a Schedule TO-I offering to spend $30 million buying its own shares.

Those two facts are not contradictory, and anyone who tells you they are is selling something. A company can be short of cash for a $612 million refinancing in 2027 and still write a $30 million cheque in 2026; the amounts are different by a factor of twenty, and the second is a discretionary use of capital while the first is a wall. But a holder deciding whether to sell at $33.00 is entitled to see both, and to notice what connects them — which is the third fact, and the one that has not been reported anywhere we can find.

The offer was conditioned on a loan. It closed on September 28, from a lender related to the adviser

VineBrook held $24.5 million of cash and cash equivalents at June 30, 2026, excluding restricted cash. The offer would cost about $31 million including roughly $1 million of fees and expenses. The company therefore does not have the money on hand, and the Offer to Purchase says so plainly:

"We intend to fund the purchase of Shares in the Offer and pay related costs using, in part, our available cash (which does not include restricted cash) and with the net proceeds from a debt financing."

That financing is a condition of the offer, not a detail of it. The Financing Condition requires a debt financing producing gross proceeds of no less than $25.0 million. If it does not happen, VineBrook is not obliged to buy anything. And the filing adds a sentence that is unusual to see in print:

"The Company currently does not have an alternative financing plan if the Financing Condition is not met."

The company expects the financing to close at least five business days before the October 5 deadline, and says that if it has not, it will amend the Schedule TO and may extend the offer. So until September 28 the practical position for a holder was this: the cash you would receive on October 5 depended on a loan that a company which has disclosed a liquidity shortfall had not yet closed, and for which it had no backup.

Update, September 29: the loan has closed, and who lent it matters. On September 28, 2026 VineBrook filed Amendment No. 2 to the Schedule TO (accession 0001437749-26-031347) and a Form 8-K (accession 0001437749-26-031348, Items 1.01 and 2.03). Through two indirect subsidiaries, VB Thirteen, LLC and VB Fourteen, LLC, it entered into a credit agreement with The Ohio State Life Insurance Company for $25.0 million. The terms, as filed:

• $4.0 million funded on September 28; the remaining $21.0 million to be funded on a date agreed with the lender "which shall be no later than October 2, 2026", three days before the offer expires.
• 10.0% a year, payable monthly, maturing September 28, 2027. A 1.0% origination fee at closing and a 1.0% exit fee on any principal repaid, including the mandatory prepayments when certain properties are sold.
• Secured by a pledge of the operating partnership's interests in the two borrowers, the borrowers' interests in VB Clovis, LLC, and the proceeds of sales of certain real property; a non-recourse carve-out guaranty from the operating partnership; covenants on maximum debt to capital, minimum net asset value and minimum net operating income.
• "The Company expects to repay the Loan using cash on hand or through additional future borrowings."

Then the sentence both filings carry: "OSL may be deemed to be an affiliate of NexPoint Real Estate Advisors V, L.P., the Company's external Adviser, through common beneficial ownership." And on the condition itself: "Upon entering into the Credit Agreement, the Company deems the Financing Condition satisfied and, to the extent not satisfied, waives such condition." The condition is treated as met on signing, with $21.0 million of the $25.0 million (84%) not yet funded.

Three things a holder can do with that. The price of the money: 10.0% for one year, against the 5.948% the company agreed with MassMutual on August 14 for $547.0 million over five years; at 10.0%, $25.0 million costs $2.5 million of interest a year before the two 1.0% fees (our arithmetic). Who is on the other side: the shares are being bought back with money lent by an entity the company itself says may be an affiliate of the firm that advises it and recommends its NAV; neither filing says how the terms were approved or whether independent directors reviewed them. The minimum-NAV covenant: the loan contains one, and the 8-K does not print the threshold; the credit agreement is filed as Exhibit 10.1 to the 8-K. None of this is a reason to tender or not to tender. It is what changed since the offer was printed.

The earlier amendment was not this. On September 22, 2026 VineBrook filed Amendment No. 1 to the Schedule TO (accession 0001437749-26-030920). It says nothing about the financing. As of September 23, 2026 the company's EDGAR file contains no filing reporting that the Financing Condition has been satisfied, and the five-business-day mark the company set itself falls on September 28. A holder who sees "SC TO-I/A" appear on EDGAR and assumes the loan closed would be reading the wrong document. What the amendment actually does is the subject of the next section, and it is not small.

The amendment moved a number the offer had already printed: book value per share, $7.65 to $3.60

Amendment No. 1 is four pages and a press release. The press release describes its purpose in six words -- the company filed it "to provide certain summary financial information" -- and says nothing about changing anything. The amendment itself is more precise about its scope:

"The disclosure in the Offer to Purchase and Item 10 of Schedule TO is hereby amended and supplemented as follows... The information contained under the sub-heading 'Certain Financial Information' on page 27 of the Offer to Purchase is hereby amended and restated."

Page 27 of the Offer to Purchase, filed September 4, contained three sentences. Two of them incorporate the annual report and the June 30 Form 10-Q by reference. The third is a number:

"The Company's book value per share was $7.65 as of June 30, 2026."

The restated version, filed September 22, ends with a different number for the same date:

"The Company's book value per share as of June 30, 2026 was $3.60 per share."

Same company, same balance sheet, same reporting date, $4.05 a share less -- a 53% reduction in a figure the company had already put in front of the people it is asking to sell. Neither the amendment nor the press release says that a previously disclosed figure changed, and neither explains why.

Why a number like this is in a tender offer at all. Item 10 of Schedule TO requires the issuer to furnish the financial information specified in Item 1010(a) and (b) of Regulation M-A "if material," and Item 1010(a)(4) names one item explicitly: "Book value per share as of the date of the most recent balance sheet presented." The summary permitted instead, under Item 1010(c), names the same thing at (c)(5). Instruction 2 to Item 10 sets out when financial statements are not considered material, and it is a conjunctive test: the consideration must be solely cash, the offer must not be subject to any financing condition, and the offeror must be an EDGAR-reporting company or be bidding for the whole class. VineBrook's offer is cash, and VineBrook reports on EDGAR -- but the offer is subject to a Financing Condition. The middle limb fails, so the exemption does not apply. That is the rule; we are describing it, not alleging a breach of it.

What the restatement is, and what it is not. It is not a restatement of the financial statements. The summary tables the amendment adds tie to the 10-Q the company filed on August 14, the one this page has used since it was published: total revenues of $168.8 million for the six months to June 30, a net loss of $84.5 million, a net loss attributable to stockholders of $64.7 million, loss per share of $(2.48), total assets of $3.007 billion, total liabilities of $2.724 billion. Every one of those matches. The only figure that moved is the per-share one the regulation names.

And the one piece of arithmetic a holder can do on it does not land on either number. The same amendment prints total stockholders' (deficit) equity of $(178.8) million at June 30, 2026. Across the 26,236,818 shares outstanding stated in the Offer to Purchase, that column is negative $6.81 a share. So neither $7.65 nor $3.60 is that column divided by the share count; both include something that sits outside it -- most of the candidates are on the same page, the $267.2 million of redeemable noncontrolling interests in the operating partnership being the largest -- and the filing does not say which. A holder cannot reproduce either figure from the table printed immediately above it. We are not going to guess at the construction and then present the guess as the company's. What is on the record is two different answers to a question the SEC's own rule says must be answered, eighteen days apart, from the same balance sheet.

The series the amendment does settle. Whatever the per-share construction, the summary balance sheet puts the direction beyond argument. Total stockholders' equity was positive $154.3 million at December 31, 2024, negative $70.4 million at December 31, 2025, and negative $178.8 million at June 30, 2026 -- a swing of $333.1 million in eighteen months, while the NAV the offer is priced against moved from $54.54 to $52.68.

What it changes for the decision, honestly stated. Not much, mechanically: book value is depreciated historic cost, a REIT's book equity is expected to sit far below an appraisal, and nobody sensible prices a single-family rental portfolio off it. The $33.00 is still 62.6% of the mark the board set, and that comparison is still the one that matters most. What it changes is the weight you put on the offer document itself. This is the second number in three weeks that a holder can only get right by reading a later filing -- the first being the status of the Financing Condition -- and the company announced the change as a routine addition of "summary financial information". If you are deciding by October 5, the practical lesson is the one this page keeps arriving at: read the amendments, not the press releases.

What $33.00 is, measured three ways

Against the company's own NAV. $52.68 was set on August 14, 2026, as of June 30, 2026, on a fully diluted basis, and it is unaudited. At $33.00 a holder gives up $19.68 a share of stated value. If the offer fills, 909,090 shares change hands and about $17.9 million of stated value is exchanged for cash. The 62.6% figure is the company's own; the $19.68 and the $17.9 million are our arithmetic on it.

Against the NAV series. The company publishes its history, and it does not look like a collapse:

That is a band of about two dollars over eighteen months, with the June 2026 mark the lowest of the seven and the only one below $54. The published table starts at December 2024, so it is not a full history; a separate footnote in the March 2026 10-Q, disclosing the value of restricted stock units, records the NAV in effect at each grant date — $54.54 in April 2025, $58.95 in April 2024, $63.04 in April 2023 and $54.14 in February 2022. We are not calling $63.04 a peak, because we have not seen the quarters around it. What those four points do establish is that the mark was materially higher in 2023 and 2024 than it is now.

Against what the company earns. This is where the stated value and the operating numbers pull apart. For the six months to June 30, 2026, VineBrook reported a net loss attributable to stockholders of $64.7 million and FFO of negative $40.4 million, which is negative $1.25 a share. Over the same six months it declared $1.0602 a share in distributions, and on August 10 it approved another $0.5301, paid on August 19. The company does not hide the gap — it publishes the coverage ratios itself, and for the six months they read FFO -1.18x, Core FFO -0.36x, AFFO -0.66x. A negative coverage ratio means the distribution is not being funded by the property portfolio's earnings on any of the three measures the company reports.

The losses are shrinking: the comparable prior-year figures were a $89.2 million net loss and negative $1.86 of FFO per share. But a holder weighing $33.00 against $52.68 should know that the $52.68 is an appraisal of assets, while the operating statements underneath it are negative and the distribution is being paid anyway.

Against what the shares actually change hands for — which the Board used and did not print. This is the fourth measure, and it is missing. The Offer to Purchase says the Board set $33.00 after considering the most recent NAV, "the prices that LODAS Securities, LLC has advised us Shares have traded between stockholders through its market making service," and the prices at which the listed single-family rental REITs American Homes 4 Rent (NYSE: AMH) and Invitation Homes (NYSE: INVH) trade relative to their own estimated NAVs. Neither input is disclosed. Not one secondary trade price appears in the Offer to Purchase, the Letter of Transmittal, the 2025 Form 10-K or the June 2026 Form 10-Q, and no AMH or INVH discount is given. So the only market that exists for these shares was an input to the price, and the holder being asked to accept or refuse that price is not shown it.

The company is also careful not to defend the number. After stating that $33.00 is below the $52.68 NAV, the Offer to Purchase adds seven words that a holder should read twice:

"We in no way suggest that $33.00 per Share is the fair value of our Shares."

Neither the company, nor the Board, nor RBC Capital Markets as dealer manager, nor NexPoint Securities as information agent makes any recommendation on whether to tender.

What you actually get if you tender

Three mechanics decide what a tendering holder receives, and one of them is a difference from the other non-traded REIT self-tender running this month.

Proration, with no odd-lot door. If more than 909,090 shares are tendered, the paying agent applies one factor to everybody: 909,090 — or the increased number, if the company uses its discretion — divided by the total validly tendered and not withdrawn. Many non-traded REIT self-tenders buy out small holders in full first; Highlands REIT's offer, which closes on September 29, does exactly that. VineBrook's does not. The words "odd lot" do not appear in the Offer to Purchase or the Letter of Transmittal at all. A holder of 400 shares is cut by the same factor as a holder of 40,000. If three times the maximum is tendered, a 1,000-share holder sells roughly 333 shares and keeps the rest.

The 2% discretion. The company may increase the number accepted by up to 2% of the shares outstanding — about 524,736 shares, or up to roughly $17.3 million more — without amending or extending the offer. That is funded from the same place as the rest, which is to say from the loan, which closed on September 28 with $21.0 million of it still to be funded by October 2.

Who is not in the queue. The offer is for Class A common stock only. At June 30, 2026 there were also 23,512,787 OP units outstanding, of which NexPoint-affiliated entities and the original VineBrook contributors hold the Class B and Class C units; those are not eligible. And the company has been advised that none of its directors or executive officers intend to tender any shares. There were approximately 6,767 record holders of Class A common stock at the date of the 2025 Form 10-K.

And the date that matters is not October 5. The Financing Condition has to be satisfied or waived at least five business days before expiry. Counting back from Monday, October 5 — October 2, October 1, September 30, September 29 — that is Monday, September 28. If the loan had not closed by then, the company said it would amend the Schedule TO and extend the offer if needed. It closed that day (Amendment No. 2, September 28), so the October 5 deadline stands unless the company extends it.

What "suspended since December 2022" has actually meant

The Offer to Purchase dates the suspension to December 2022. The 10-Q and the 2025 Form 10-K date it to July 28, 2025. Both are true, and the way they reconcile is the part a holder wants.

The general programme stopped in the fourth quarter of 2022. What kept running was the exception window, and the Item 5 tables show how small it is: no repurchases at all in October or November of either 2024 or 2025, then 21,410 shares at an average $55.45 in December 2024 and 46,913 shares at an average $54.84 in December 2025. Against the shares outstanding at the time those are 0.08% and 0.18%. On July 28, 2025 the Board formalised what had been the practice for two and a half years.

So the honest way to describe the gate is: almost four years, with a death-and-hardship door that opens for a few weeks each December, at full NAV. The first general offer since then is at 62.6% of that NAV, and the hardship door is closed for the duration of the offer and ten business days after it.

What the balance sheet looks like under the appraisal

VineBrook is a large company: $3.01 billion of total assets at June 30, 2026, down from $3.15 billion at December 31, 2025, and 19,689 homes in the VineBrook Portfolio alone. The debt is correspondingly large. Aggregate scheduled maturities over the next five calendar years total $2.66 billion, and they are not evenly spread:

Against that, the statement is titled "Consolidated Statements of Stockholders' Equity (Deficit)" and it earns the parenthesis: the Total column stands at negative $178.8 million at June 30, 2026, after $927.9 million of distributions in excess of retained earnings. That column covers the Series B preferred, the Class A common, paid-in capital and other comprehensive income; the Series A preferred and the noncontrolling interests sit outside it. It has also deepened fast — the same column read negative $125.4 million three months earlier, a $53.4 million move in a single quarter, of which $14.2 million was the common distribution.

That is not the scandal it first looks like: a REIT that has depreciated a large portfolio for years will show book equity far below appraised value, which is the whole reason NAV exists as a separate number. It does mean that every dollar of the $52.68 comes from the appraisal, not from the audited balance sheet — and that the appraisal is produced by the Adviser, which calculates NAV and recommends it to the Pricing Committee, and which is paid 0.75% of gross asset value a year. Ahead of the common sit two preferred stacks: 4,996,000 Series A shares carried at $123.8 million, and 2,548,240 Series B shares, whose holders are entitled on liquidation to $25.00 a share plus accrued distributions, after the company's debts and other liabilities.

The part that argues the other way, in full

A forensic read that only assembles the bad numbers is an advertisement with footnotes. Here is the company's side, and it is substantial.

It refinanced $547 million on the same day. On August 14, 2026 — the day the 10-Q was filed and the day the NAV was set — VineBrook's operating partnership closed a $547.0 million interest-only term loan with Massachusetts Mutual Life Insurance Company and MassMutual Ascend, at 5.948%, maturing August 14, 2031, funded at a 3.0% original issue discount. That is a serious lender writing a serious cheque at a normal rate, and it is evidence against the reading that nobody will lend to VineBrook. Note precisely what it did and did not do: the proceeds repaid the JPM Term Loan and the Bluerock Loan, and neither of those is among the four obligations named in the liquidity paragraph. The $612.2 million is what remained after that refinancing, disclosed on the same day.

It is selling homes, and the sales are happening. The company states an intent to sell approximately 3,750 homes over the next twelve months and to use the proceeds against debt. After June 30 it disposed of 396 homes for about $50.8 million of net proceeds, while acquiring 58 for $17.8 million. That is a real disposition programme, not a plan on a slide.

It says it will meet its covenants and that refinancing is probable. The going-concern note records that management "currently projects" it will meet its debt covenants and that, having assessed its history of obtaining financing, its creditworthiness and current debt market conditions, it "concluded it is probable that the refinancings will be completed prior to the maturity dates." The same paragraph adds: "There can be no assurances that financing can be obtained."

And the offer does give holders something they have not had. Nobody has been able to sell these shares back to the company at any price since December 2022 unless they died or suffered a qualifying hardship. A $33.00 bid is the first exit in nearly four years.

One data point cuts the other way and belongs here too. On July 2, 2026, VineBrook's operating partnership borrowed $30.0 million on a one-year interest-only basis at a 10.0% fixed rate — and OSL, an entity the filing says may be deemed an affiliate of the Adviser through common beneficial ownership, took $15.0 million of that loan. A 10% one-year loan half-funded by an affiliate of your own manager is an expensive bridge. It was repaid six weeks later with the MassMutual proceeds.

So should you tender?

We do not answer that, and anyone who answers it from a web page without knowing your tax basis, your other holdings and when you need the money is guessing. What we can do is lay out the four questions the filings let you answer for yourself.

Do you need cash before the repurchase plan reopens, and do you know when that is? Nobody does — the plan has been suspended since December 2022 with no stated reopening date, and it is blocked during the offer and for ten business days afterwards even for hardship. If your answer is that you need liquidity within a knowable horizon, $33.00 is the only knowable number in front of you.

Do you believe the $52.68? It is unaudited, set as of June 30, produced by the Adviser and approved by a committee of the Board, using a methodology in which the Adviser recommends a range and the committee takes the midpoint. Under it sits a portfolio that lost $64.7 million in six months and pays a distribution its own FFO does not cover. If you think $52.68 is broadly right, $33.00 is a 37.4% haircut for immediacy. If you think the mark is generous, the haircut is smaller than it looks.

Have you priced the distribution you keep by not tendering? At the current $0.5301 quarterly rate, a share pays $2.1204 a year — 6.4% on the $33.00 you would be paid, 4.0% on the $52.68 you would be giving up. Holding is not free of risk, but it is not a zero-yield wait either. Whether that distribution survives a year in which the company must refinance is a separate question, and the coverage ratios above are the relevant evidence.

And have you noticed that the offer may not close? If the Financing Condition is not met, there is no $33.00. The company has told you there is no alternative plan. Between now and October 5, the single most useful thing a holder can do is watch EDGAR for an amendment to the Schedule TO reporting that the financing has closed.

After the result (October 7, 2026). The financing condition was treated as met and the offer closed oversubscribed about three times. If you tendered, expect cash for roughly a third of what you offered and the rest of your shares back in your account; the repurchase plan stays blocked, even for hardship, for ten business days after the offer, and the general plan has been suspended since December 2022. Whether VineBrook runs another tender, and at what price, is not said in any filing. The final count will be in a further amendment to the Schedule TO.

How we checked this

Every figure above comes from one of seven documents on SEC EDGAR, and the CSV records which: the Schedule TO-I and Offer to Purchase filed September 4, 2026 (accession 0001437749-26-029656), Amendment No. 1 to the Schedule TO, filed September 22, 2026 (accession 0001437749-26-030920, with its press release at Exhibit 99(a)(5)(B)), the Form 10-Q for the quarter ended June 30, 2026, filed August 14, 2026 (accession 0001193125-26-351798), and the Form 10-Q for the quarter ended March 31, 2026 (accession 0001193125-26-214098) for the NAV history and the grant-date valuations. The repurchase chronology adds three more: the Form 10-K for 2022 (accession 0001755755-23-000003) for the fourth-quarter-2022 suspension, and the Forms 10-K for 2024 (accession 0001755755-25-000005) and 10-K for 2025 (accession 0001193125-26-102071) for the Item 5 repurchase tables, the record-holder count and the July 28, 2025 indefinite suspension. Where a number is ours rather than the company's — the 37.4% discount, the $19.68 a share, the $17.9 million aggregate, the 3.46% of shares outstanding, the 4.9%, the 0.08% and 0.18% December windows, the September 28 financing deadline and the annualised distribution yields — the CSV labels it as our arithmetic.

One label to be careful with, for anyone editing this page later. The June 2026 Form 10-Q uses the line name "Net loss attributable to stockholders" twice, at two different scopes. The consolidated statement of operations gives $(64,732) thousand for the six months, which is the figure used above and the one that ties to the $(2.48) loss per share on 26,113 thousand weighted shares. The VineBrook FFO reconciliation, which covers the VineBrook Portfolio segment and excludes NexPoint Homes, gives $(54,108) thousand for the same six months, with VineBrook FFO of $(32,927) thousand and VineBrook AFFO per diluted share of $(0.43). Both are real and neither contradicts the other; a reader who checks one against the other without reading the table headings will think one of them is wrong.

One cross-check worth stating, because it validates the share count everything else rests on: the Offer to Purchase says the company may increase the shares it accepts by up to 2% of those outstanding, at an additional cost of "approximately $17.3 million." Two per cent of 26,236,818 shares is 524,736 shares, which at $33.00 is $17,316,300. The filing's own figure and ours agree, so the 26,236,818 denominator is the right one.

We checked the company's EDGAR filing history on September 21 and again on September 23, 2026: this is the first Schedule TO of any kind VineBrook Homes Trust has filed, and Amendment No. 1 is the only amendment to it. The two book-value sentences were also checked against EDGAR full-text search, which returns the phrase "book value per share" in exactly five VineBrook documents; the two that matter are the Offer to Purchase and the amendment, and they disagree. And we have not found any reporting that connects the tender offer to the liquidity disclosure or to the Financing Condition — but "we did not find it" is not "it does not exist," and that sentence carries no weight in the decision. Everything that does carry weight is in the filings linked above, where you can check it yourself.

What this page does not say. We are not reporting a default, an insolvency or a failure to pay. The company has not missed a payment, its lenders have not declared anything, and a disclosed liquidity gap twelve months ahead of a maturity is a normal thing for a leveraged REIT to disclose — it is why the going-concern note exists. We are also not saying the offer is unfair: a board may rationally buy shares below its own NAV, and holders who need cash may rationally sell below it. What we are saying is narrower and entirely factual: the price is 62.6% of the issuer's own mark, the issuer is borrowing to pay it, and the issuer has disclosed that it cannot currently cover a much larger obligation coming due next year. A holder deciding by October 5 should be looking at all three.